Adjuvant therapy in patients with resected poor-risk head and neck cancer.
about
Pre-operative tracheostomy does not impact on stomal recurrence and overall survival in patients undergoing primary laryngectomy.Head and neck cancer: an evolving treatment paradigm.Surgical management of the N0 neck in early stage T1-2 oral cancer; a personal perspective of early and late impalpable disease.Selective neck dissection as a therapeutic option in management of squamous cell carcinoma of unknown primary.Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines.Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.Primary radical ablative surgery and fibula free-flap reconstruction for T4 oral cavity squamous cell carcinoma with mandibular invasion: oncologic and functional results and their predictive factors.Modified weekly cisplatin-based chemotherapy is acceptable in postoperative concurrent chemoradiotherapy for locally advanced head and neck cancerTransoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.
P2860
Q34439989-E7B1D9C1-D019-4FDD-AA39-2B2B2AD712C2Q37271937-1BB2A8F4-8B72-46AE-B2EB-8D4AE80AD109Q38009701-0A27A79E-6858-4A01-B824-769D083C8F70Q38124709-5C0ED443-7457-4953-87FB-742BC8B06EB0Q40060699-1CD7CD26-6A7A-4B9F-9A95-633DA01FB782Q40187157-A0B3125F-9351-4411-A9AB-180BF14C7AF2Q40641801-5C03DDBC-3DE3-4E4F-BD85-30EADE2E1EADQ42110246-6F321CA7-5B0F-40A6-891B-6E2BA550F3EFQ46425931-6068BB02-D01A-44DA-87BB-03E43CE3CF72
P2860
Adjuvant therapy in patients with resected poor-risk head and neck cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Adjuvant therapy in patients with resected poor-risk head and neck cancer.
@ast
Adjuvant therapy in patients with resected poor-risk head and neck cancer.
@en
type
label
Adjuvant therapy in patients with resected poor-risk head and neck cancer.
@ast
Adjuvant therapy in patients with resected poor-risk head and neck cancer.
@en
prefLabel
Adjuvant therapy in patients with resected poor-risk head and neck cancer.
@ast
Adjuvant therapy in patients with resected poor-risk head and neck cancer.
@en
P2093
P356
P1476
Adjuvant therapy in patients with resected poor-risk head and neck cancer.
@en
P2093
Jacques Bernier
Jan B Vermorken
Wayne M Koch
P304
P356
10.1200/JCO.2005.05.0906
P407
P577
2006-06-01T00:00:00Z